- Betrixaban represents the first oral and long-lasting treatment to prevent deep vein thrombosis and pulmonary embolisms in acutely ill nonsurgical patients.
- The Oncomine Dx Target Test assesses tumor samples for the presence of biomarkers associated with three drug therapies approved to treat non-small cell lung cancer.
- Nevisense is a device intended to help clinicians detect early stages of malignant melanoma.
- The ClearLLab test detects several types of blood and lymphatic cancers.
- Illumina’s next-generation sequencing kit helps clinicians identify which patients are eligible for treatment with Amgen’s cancer drug Vectibix.
More articles on supply chain:
New York City faces critical blood shortage
UPS’ newest delivery vehicles? Golf carts
6 drug, device recalls in June
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
